Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Marfan Syndrome | 24 | 2023 | 240 | 4.670 |
Why?
|
Atenolol | 12 | 2020 | 100 | 3.250 |
Why?
|
Losartan | 12 | 2020 | 299 | 2.850 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 10 | 2020 | 451 | 2.390 |
Why?
|
Aorta | 11 | 2023 | 2062 | 1.570 |
Why?
|
Adrenergic beta-Antagonists | 6 | 2022 | 1240 | 1.360 |
Why?
|
Connective Tissue Diseases | 4 | 2017 | 264 | 1.310 |
Why?
|
Aortic Diseases | 7 | 2023 | 743 | 1.050 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 4 | 2020 | 30 | 0.960 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2015 | 691 | 0.930 |
Why?
|
Aortic Aneurysm | 4 | 2015 | 644 | 0.850 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2021 | 44 | 0.760 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2021 | 326 | 0.700 |
Why?
|
Chromosome Deletion | 2 | 2023 | 1401 | 0.580 |
Why?
|
Vertebral Artery | 2 | 2014 | 192 | 0.480 |
Why?
|
Skin Diseases, Genetic | 1 | 2014 | 41 | 0.470 |
Why?
|
Noonan Syndrome | 2 | 2014 | 122 | 0.460 |
Why?
|
Heart Valve Diseases | 3 | 2023 | 1074 | 0.440 |
Why?
|
Aortic Valve | 7 | 2023 | 1924 | 0.400 |
Why?
|
Aneurysm | 1 | 2014 | 339 | 0.390 |
Why?
|
Infant | 31 | 2023 | 35134 | 0.390 |
Why?
|
Arteries | 2 | 2023 | 1119 | 0.380 |
Why?
|
Child, Preschool | 35 | 2021 | 41005 | 0.370 |
Why?
|
Loeys-Dietz Syndrome | 3 | 2023 | 40 | 0.360 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2703 | 0.350 |
Why?
|
Vascular Malformations | 1 | 2014 | 454 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2269 | 0.320 |
Why?
|
Dilatation, Pathologic | 4 | 2020 | 520 | 0.310 |
Why?
|
Joint Instability | 1 | 2014 | 792 | 0.290 |
Why?
|
Echocardiography | 9 | 2023 | 5099 | 0.280 |
Why?
|
Child | 30 | 2023 | 77709 | 0.270 |
Why?
|
Heart Septal Defects, Ventricular | 3 | 2011 | 488 | 0.230 |
Why?
|
Aortic Valve Insufficiency | 2 | 2020 | 579 | 0.230 |
Why?
|
Chromosome Disorders | 4 | 2023 | 514 | 0.230 |
Why?
|
Heart Septal Defects, Atrial | 3 | 2011 | 478 | 0.230 |
Why?
|
Magnetic Resonance Angiography | 3 | 2015 | 1443 | 0.220 |
Why?
|
Ectopia Lentis | 1 | 2022 | 20 | 0.210 |
Why?
|
Adolescent | 23 | 2023 | 85779 | 0.200 |
Why?
|
Collagen Type V | 1 | 2021 | 16 | 0.200 |
Why?
|
Transcription Factors | 1 | 2021 | 12207 | 0.190 |
Why?
|
Mitral Valve Insufficiency | 4 | 2018 | 1421 | 0.190 |
Why?
|
Collagen Type III | 1 | 2021 | 90 | 0.190 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2020 | 51 | 0.190 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2017 | 964 | 0.180 |
Why?
|
Dwarfism | 1 | 2021 | 146 | 0.180 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7914 | 0.180 |
Why?
|
Aortic Coarctation | 2 | 2015 | 281 | 0.170 |
Why?
|
Female | 45 | 2023 | 380193 | 0.170 |
Why?
|
Male | 41 | 2023 | 350115 | 0.170 |
Why?
|
Phenotype | 7 | 2023 | 16367 | 0.160 |
Why?
|
Young Adult | 12 | 2020 | 56429 | 0.160 |
Why?
|
Humans | 67 | 2023 | 744366 | 0.150 |
Why?
|
Aorta, Thoracic | 2 | 2017 | 1084 | 0.150 |
Why?
|
Thinness | 1 | 2021 | 480 | 0.150 |
Why?
|
Retrospective Studies | 14 | 2020 | 77460 | 0.150 |
Why?
|
Adult | 22 | 2023 | 214052 | 0.140 |
Why?
|
Microcephaly | 1 | 2021 | 432 | 0.140 |
Why?
|
Infant, Newborn | 16 | 2023 | 25628 | 0.140 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4805 | 0.140 |
Why?
|
Aortic Valve Stenosis | 3 | 2020 | 1965 | 0.130 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2018 | 585 | 0.130 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2015 | 45 | 0.130 |
Why?
|
Hypertension, Pulmonary | 2 | 2021 | 1534 | 0.130 |
Why?
|
Face | 1 | 2021 | 994 | 0.120 |
Why?
|
Heart Defects, Congenital | 5 | 2018 | 4583 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2022 | 923 | 0.120 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2015 | 209 | 0.110 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2018 | 591 | 0.110 |
Why?
|
Intestinal Polyposis | 1 | 2012 | 44 | 0.110 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2022 | 1516 | 0.110 |
Why?
|
Smad4 Protein | 1 | 2012 | 163 | 0.100 |
Why?
|
Gestational Age | 1 | 2021 | 3493 | 0.100 |
Why?
|
Antihypertensive Agents | 2 | 2018 | 2047 | 0.100 |
Why?
|
Echocardiography, Doppler | 2 | 2012 | 935 | 0.100 |
Why?
|
Early Termination of Clinical Trials | 1 | 2011 | 68 | 0.100 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2012 | 139 | 0.100 |
Why?
|
Pilot Projects | 3 | 2020 | 8319 | 0.090 |
Why?
|
Heart Septal Defects | 1 | 2011 | 192 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 3 | 2011 | 3537 | 0.090 |
Why?
|
Linear Models | 3 | 2018 | 5953 | 0.090 |
Why?
|
Pulmonary Artery | 2 | 2013 | 1912 | 0.090 |
Why?
|
Heart | 1 | 2023 | 4464 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1342 | 0.090 |
Why?
|
Mitral Valve | 1 | 2018 | 1491 | 0.090 |
Why?
|
Patient Compliance | 1 | 2020 | 2684 | 0.090 |
Why?
|
Abnormalities, Multiple | 6 | 2011 | 1416 | 0.090 |
Why?
|
Follow-Up Studies | 8 | 2020 | 39052 | 0.090 |
Why?
|
Treatment Outcome | 10 | 2018 | 63107 | 0.090 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 1476 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 9955 | 0.080 |
Why?
|
Enalapril | 1 | 2011 | 327 | 0.080 |
Why?
|
Severity of Illness Index | 6 | 2018 | 15535 | 0.080 |
Why?
|
Heart Ventricles | 2 | 2018 | 3817 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4216 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15160 | 0.080 |
Why?
|
Lymphangioma | 1 | 1988 | 65 | 0.080 |
Why?
|
Genotype | 3 | 2022 | 12952 | 0.080 |
Why?
|
Down Syndrome | 2 | 2018 | 880 | 0.080 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 1987 | 40 | 0.080 |
Why?
|
Genitalia, Female | 1 | 1988 | 146 | 0.070 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2011 | 573 | 0.070 |
Why?
|
Turner Syndrome | 1 | 1988 | 130 | 0.070 |
Why?
|
Heart Block | 1 | 2008 | 410 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1768 | 0.070 |
Why?
|
Catheterization | 1 | 2012 | 1470 | 0.070 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 602 | 0.070 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1420 | 0.070 |
Why?
|
Umbilical Cord | 1 | 1987 | 180 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2023 | 19905 | 0.070 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 1987 | 373 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1903 | 0.070 |
Why?
|
Mutation | 5 | 2022 | 29786 | 0.060 |
Why?
|
Ultrasonography, Prenatal | 3 | 2002 | 1695 | 0.060 |
Why?
|
Heart Neoplasms | 1 | 1987 | 374 | 0.060 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2007 | 306 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6896 | 0.060 |
Why?
|
Edema | 1 | 1988 | 789 | 0.060 |
Why?
|
Williams Syndrome | 2 | 2013 | 187 | 0.060 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2011 | 364 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 3595 | 0.050 |
Why?
|
Age Factors | 3 | 2015 | 18373 | 0.050 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2023 | 351 | 0.050 |
Why?
|
Hospitals, Pediatric | 1 | 2011 | 1775 | 0.050 |
Why?
|
Chromosome Aberrations | 2 | 1999 | 1813 | 0.050 |
Why?
|
Carcinoma, Basal Cell | 1 | 1987 | 545 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12073 | 0.050 |
Why?
|
Infant, Premature, Diseases | 1 | 2007 | 707 | 0.050 |
Why?
|
Quality of Life | 2 | 2023 | 12802 | 0.050 |
Why?
|
Hernia, Diaphragmatic | 1 | 2002 | 250 | 0.050 |
Why?
|
United States | 6 | 2018 | 69872 | 0.050 |
Why?
|
Dextrocardia | 1 | 2000 | 37 | 0.050 |
Why?
|
Disease Progression | 2 | 2018 | 13286 | 0.050 |
Why?
|
Cardiovascular Abnormalities | 1 | 1999 | 144 | 0.040 |
Why?
|
Prognosis | 3 | 2018 | 29060 | 0.040 |
Why?
|
Cardiomegaly | 1 | 2001 | 620 | 0.040 |
Why?
|
Fatal Outcome | 2 | 2019 | 1851 | 0.040 |
Why?
|
Dilatation | 1 | 2018 | 291 | 0.040 |
Why?
|
Research Design | 2 | 2015 | 5984 | 0.040 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2017 | 89 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2019 | 6171 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1490 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2020 | 789 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3508 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 269 | 0.030 |
Why?
|
Aneuploidy | 1 | 2018 | 530 | 0.030 |
Why?
|
Prospective Studies | 7 | 2023 | 53290 | 0.030 |
Why?
|
Death, Sudden | 1 | 1996 | 302 | 0.030 |
Why?
|
Middle Aged | 5 | 2023 | 213390 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1252 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1461 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2005 | 1537 | 0.030 |
Why?
|
American Heart Association | 1 | 2018 | 1057 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3339 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 1988 | 2736 | 0.030 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2013 | 30 | 0.030 |
Why?
|
Alagille Syndrome | 1 | 2013 | 35 | 0.030 |
Why?
|
Risk Assessment | 4 | 2018 | 23336 | 0.030 |
Why?
|
Genetic Variation | 2 | 2019 | 6542 | 0.030 |
Why?
|
Risk Factors | 4 | 2018 | 72296 | 0.030 |
Why?
|
Phosphoglucomutase | 1 | 1992 | 6 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2018 | 970 | 0.030 |
Why?
|
Calsequestrin | 1 | 1992 | 30 | 0.030 |
Why?
|
Lung | 2 | 2002 | 9857 | 0.030 |
Why?
|
Smad3 Protein | 1 | 2012 | 180 | 0.030 |
Why?
|
Sarcoplasmic Reticulum | 1 | 1992 | 158 | 0.030 |
Why?
|
Stroke Volume | 2 | 2018 | 5006 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 655 | 0.030 |
Why?
|
Fetal Death | 2 | 1999 | 448 | 0.030 |
Why?
|
Hemodynamics | 2 | 2013 | 4196 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 314 | 0.020 |
Why?
|
Smith-Magenis Syndrome | 1 | 2011 | 19 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2751 | 0.020 |
Why?
|
Constriction, Pathologic | 2 | 2013 | 1107 | 0.020 |
Why?
|
Chromosome Duplication | 1 | 2011 | 74 | 0.020 |
Why?
|
Genes, Dominant | 2 | 1998 | 880 | 0.020 |
Why?
|
Angioplasty | 1 | 2013 | 364 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3528 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2023 | 4463 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 1941 | 0.020 |
Why?
|
Fetus | 3 | 2002 | 1880 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4933 | 0.020 |
Why?
|
Survival Rate | 2 | 2018 | 12788 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 496 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 1992 | 497 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2063 | 0.020 |
Why?
|
Carbamazepine | 1 | 1989 | 229 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1539 | 0.020 |
Why?
|
DNA | 2 | 2020 | 7294 | 0.020 |
Why?
|
Orofaciodigital Syndromes | 1 | 1987 | 23 | 0.020 |
Why?
|
Reoperation | 2 | 2010 | 4201 | 0.020 |
Why?
|
Branchial Region | 1 | 1987 | 35 | 0.020 |
Why?
|
Isoenzymes | 1 | 1992 | 1728 | 0.020 |
Why?
|
Situs Inversus | 1 | 1987 | 64 | 0.020 |
Why?
|
Pedigree | 3 | 1998 | 4642 | 0.020 |
Why?
|
Muscles | 1 | 1992 | 1614 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15297 | 0.020 |
Why?
|
Microphthalmos | 1 | 1987 | 54 | 0.020 |
Why?
|
Surface-Active Agents | 1 | 2007 | 159 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1152 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6539 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13409 | 0.020 |
Why?
|
Length of Stay | 2 | 2010 | 6311 | 0.020 |
Why?
|
Sex Distribution | 1 | 2012 | 2297 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2891 | 0.020 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1989 | 317 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2010 | 5316 | 0.020 |
Why?
|
Hand Deformities, Congenital | 1 | 1987 | 146 | 0.020 |
Why?
|
Base Sequence | 3 | 2011 | 12797 | 0.020 |
Why?
|
Age Distribution | 1 | 2012 | 2902 | 0.020 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2010 | 349 | 0.020 |
Why?
|
Syndrome | 4 | 1998 | 3252 | 0.020 |
Why?
|
Twins | 1 | 1987 | 339 | 0.020 |
Why?
|
Genome, Human | 1 | 2019 | 4420 | 0.020 |
Why?
|
Lip | 1 | 1987 | 195 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
Canada | 1 | 2010 | 2065 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3531 | 0.020 |
Why?
|
Placenta Diseases | 1 | 1987 | 199 | 0.020 |
Why?
|
Karyotyping | 1 | 1987 | 1243 | 0.020 |
Why?
|
Abortion, Induced | 2 | 2002 | 458 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 2007 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 1996 | 1912 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 2649 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6366 | 0.010 |
Why?
|
X Chromosome | 1 | 1987 | 814 | 0.010 |
Why?
|
Facial Expression | 1 | 1987 | 508 | 0.010 |
Why?
|
Phosphoproteins | 1 | 1992 | 2441 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12356 | 0.010 |
Why?
|
Growth Disorders | 1 | 1987 | 645 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4185 | 0.010 |
Why?
|
Genetic Testing | 1 | 2015 | 3444 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1987 | 2421 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2002 | 438 | 0.010 |
Why?
|
Spleen | 1 | 1987 | 2362 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4328 | 0.010 |
Why?
|
Functional Laterality | 1 | 1987 | 2290 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2005 | 1206 | 0.010 |
Why?
|
Myocardium | 1 | 1992 | 4772 | 0.010 |
Why?
|
Gene Expression | 1 | 1992 | 7798 | 0.010 |
Why?
|
Amniocentesis | 1 | 1999 | 116 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15520 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4671 | 0.010 |
Why?
|
Pregnancy, High-Risk | 1 | 1999 | 120 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2011 | 3666 | 0.010 |
Why?
|
Pregnancy | 4 | 2000 | 29144 | 0.010 |
Why?
|
Placenta | 1 | 1987 | 1699 | 0.010 |
Why?
|
Cohort Studies | 2 | 2012 | 40559 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9849 | 0.010 |
Why?
|
Critical Care | 1 | 2010 | 2647 | 0.010 |
Why?
|
Prevalence | 2 | 2008 | 15221 | 0.010 |
Why?
|
Toes | 1 | 1998 | 206 | 0.010 |
Why?
|
Kidney | 1 | 1993 | 7184 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9647 | 0.010 |
Why?
|
Organ Size | 1 | 2002 | 2251 | 0.010 |
Why?
|
Maternal Age | 1 | 1999 | 802 | 0.010 |
Why?
|
Scalp | 1 | 1998 | 380 | 0.010 |
Why?
|
Fingers | 1 | 1998 | 513 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10388 | 0.010 |
Why?
|
Coronary Circulation | 1 | 1981 | 1572 | 0.010 |
Why?
|
Ventricular Outflow Obstruction | 1 | 1996 | 272 | 0.010 |
Why?
|
Neuromuscular Diseases | 1 | 1996 | 247 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 20952 | 0.010 |
Why?
|
Nephrocalcinosis | 1 | 1993 | 48 | 0.010 |
Why?
|
Chromatography | 1 | 1992 | 206 | 0.010 |
Why?
|
Hydroxyapatites | 1 | 1992 | 75 | 0.010 |
Why?
|
Calcium-Transporting ATPases | 1 | 1992 | 123 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1999 | 1236 | 0.010 |
Why?
|
Durapatite | 1 | 1992 | 161 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1992 | 549 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 708 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1992 | 1581 | 0.010 |
Why?
|
Time Factors | 2 | 2010 | 40075 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1992 | 13814 | 0.010 |
Why?
|
Molecular Weight | 1 | 1992 | 2255 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1801 | 0.010 |
Why?
|
Radiography | 1 | 2001 | 7023 | 0.010 |
Why?
|
Gene Library | 1 | 1992 | 1074 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23404 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1992 | 18111 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10252 | 0.010 |
Why?
|
Hemorrhage | 1 | 1981 | 3461 | 0.010 |
Why?
|
Calcium Channels | 1 | 1992 | 622 | 0.010 |
Why?
|
Heart Failure | 1 | 1992 | 10895 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81201 | 0.000 |
Why?
|
RNA, Messenger | 2 | 1992 | 13035 | 0.000 |
Why?
|
Brain Diseases | 1 | 1996 | 1563 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1992 | 4320 | 0.000 |
Why?
|
Animals | 3 | 2015 | 168768 | 0.000 |
Why?
|
Rabbits | 1 | 1992 | 4894 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14723 | 0.000 |
Why?
|
Mexico | 1 | 1987 | 689 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15078 | 0.000 |
Why?
|
Genes, Recessive | 1 | 1987 | 641 | 0.000 |
Why?
|
Kinetics | 1 | 1992 | 6476 | 0.000 |
Why?
|
Protein Conformation | 1 | 1992 | 4010 | 0.000 |
Why?
|
Coronary Disease | 1 | 1996 | 6077 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1996 | 12961 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1992 | 5096 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1981 | 11718 | 0.000 |
Why?
|
Macaca | 1 | 1981 | 440 | 0.000 |
Why?
|
Anticonvulsants | 1 | 1989 | 1916 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1989 | 6489 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1989 | 2795 | 0.000 |
Why?
|
Myocardial Revascularization | 1 | 1981 | 841 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1981 | 3107 | 0.000 |
Why?
|
Models, Biological | 1 | 1981 | 9584 | 0.000 |
Why?
|